Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 6/20 | 0.58 |
| ▸ | JAK3 | P52333 | 2/20 | 0.58 |
| ▸ | BTK | Q06187 | 1/20 | 0.58 |
| ▸ | TNK2 | Q07912 | 1/20 | 0.58 |
| ▸ | SRC | P12931 | 10/20 | 0.48 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.48 |
| ▸ | HCK | P08631 | 1/20 | 0.46 |
| ▸ | MAP3K7 | O43318 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | MAP2K1 | Q02750 | 2/20 | 0.46 |
| ▸ | KDR | P35968 | 2/20 | 0.45 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.45 |
| ▸ | TEK | Q02763 | 1/20 | 0.44 |
| ▸ | BRD4 | O60885 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4480775 | 0.93 | LCK (0.59) | LCKJAK3BTKTNK2SRC | |
| SCHEMBL5686436 | 0.92 | LCK (0.61) | LCKJAK3BTKTNK2SRC | |
| SCHEMBL4507641 | 0.90 | LCK (0.57) | LCKJAK3BTKTNK2SRC | |
| SCHEMBL5686185 | 0.89 | LCK (0.57) | LCKJAK3BTKTNK2SRC | |
| SCHEMBL5688959 | 0.88 | LCK (0.71) | LCKJAK3BTKTNK2SRC | |
| SCHEMBL4492079 | 0.88 | LCK (0.60) | LCKJAK3BTKTNK2SRC | |
| SCHEMBL4487653 | 0.88 | LCK (0.59) | LCKJAK3BTKTNK2SRC | |
| SCHEMBL5686293 | 0.87 | LCK (0.56) | LCKJAK3BTKTNK2SRC | |
| SCHEMBL4506388 | 0.87 | LCK (0.58) | LCKJAK3BTKTNK2SRC | |
| SCHEMBL4493453 | 0.87 | LCK (0.63) | LCKJAK3BTKTNK2SRC |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1648464-A1 | 2-AMINO-4-HYDROXY-5-PYRIMIDINCARBOXAMID DERIVATIVES AND RELATED COMPOUNDS AS T-CELL ACTIVATION INHIBITORS FOR THE TREATMENT OF INFLAMMATIONS | AMGEN INC. (US) | 2006-04-26 | — | — | EP | disclosed |
| WO-2005009443-A1 | 2-AMINO-4-HYDROXY-5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS INHIBITORS OF T CELL ACTIVATION FOR THE TREATMENT OF INFLAMMATORY DISEASES | AMGEN INC. (US) | 2005-02-03 | — | — | WO | disclosed |